First-in-Human, Open-Label, Within-Patient Controlled Study to Evaluate an Extensively Humanized Porcine Donor
Authors:
Preprint
- 20 October 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Recent human decedent model studies and compassionate xenograft use have explored the promise of porcine organs for human transplantation. To proceed to human studies, a clinically ready porcine donor must be engineered and its xenograft successfully tested in nonhuman primates. Here we describe the design, creation, and long-term life-supporting function of organs from selectively germline genome-edited pigs (SGGEP) with 11 genomic modifications. These modifications eliminated glycan xenoantigens, overexpressed human transgenes, and enhanced immunological and coagulation compatibility with human biology. In vitro analyses showed SGGEP cells possessed immunological tolerance and coagulation compatibility similar to human cells. In nonhuman primate models, kidney grafts sustained function for 447 days, and cardiac grafts survived healthily for at least 160 days. Skin grafts demonstrated life-supporting capabilities in a lethal skin removal model, facilitating complete wound closure and promoting autologous skin regeneration, remaining viable for ≥25 days without immune suppression. A clinical trial involving 31 patients with thermal burns showed that SGGEP skin grafts achieved complete and durable wound closure, with three cases not requiring autografting. These findings underscore the potential of SGGEP xenotransplantation in addressing donor organ scarcity and highlight the "one pig fits all" strategy as a promising solution for broader applications in human transplantation.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- Design and testing of a humanized porcine donor for xenotransplantationNature, 2023
- Immune recognition of porcine organs transplanted into humansThe Lancet, 2023
- Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping studyThe Lancet, 2023
- Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case reportThe Lancet, 2023
- Genetically Modified Porcine-to-Human Cardiac XenotransplantationNew England Journal of Medicine, 2022
- Skin immunity: dissecting the complex biology of our body's outer barrierMucosal Immunology, 2022
- Extensive germline genome engineering in pigsNature Biomedical Engineering, 2020
- Consistent success in life-supporting porcine cardiac xenotransplantationNature, 2018
- Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liverMolecular Metabolism, 2018
- Clinical xenotransplantation: the next medical revolution?The Lancet, 2012